2011
DOI: 10.1016/j.ehj.2011.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Comparison between the effect of intracoronary bolus of tirofiban versus eptifibatide as adjunctive antiplatelet therapy on the outcome of primary coronary intervention in patients with acute anterior ST segment elevation myocardial infarction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…A total of 176 patients with STEMI were available from three RCTs . Eptifibatide did not show significant differences compared to tirofiban in the risk of MACE and TIMI bleeding (MACE 1.89% vs15.09%, RR 0.25, 95% CI 0.06 to 1.12, P = 0.07; TIMI minor bleeding 8% vs 32.76%, RR 0.47, 95% CI 0.11 to 1.93, P = 0.22; TIMI major bleeding 0% vs 13.04%, RR 0.25, 95% CI 0.03 to 2.17, P = 0.49).…”
Section: Resultsmentioning
confidence: 98%
See 1 more Smart Citation
“…A total of 176 patients with STEMI were available from three RCTs . Eptifibatide did not show significant differences compared to tirofiban in the risk of MACE and TIMI bleeding (MACE 1.89% vs15.09%, RR 0.25, 95% CI 0.06 to 1.12, P = 0.07; TIMI minor bleeding 8% vs 32.76%, RR 0.47, 95% CI 0.11 to 1.93, P = 0.22; TIMI major bleeding 0% vs 13.04%, RR 0.25, 95% CI 0.03 to 2.17, P = 0.49).…”
Section: Resultsmentioning
confidence: 98%
“…The results of the literature search were shown in Figure 1. Finally, we identified nine eligible studies with 1256 patients, of these, four articles [19][20][21][22] in Chinese, five articles [23][24][25][26][27]…”
Section: Characteristics Of the Included Studiesmentioning
confidence: 99%